1
EXHIBIT 10.04
AMENDMENT TO ALLOS THERAPEUTICS, INC. AND CIT
AMENDED AND RESTATED ALLOSTERIC MODIFIERS OF HEMOGLOBIN
AGREEMENT
This agreement of Amendment (Amendment) is entered into as of March 12, 1996 by
and between Allos Therapeutics, Inc. (Allos) and the Center for Innovative
Technology (CIT), both corporations organized under the laws of the Commonwealth
of Virginia.
1. Allos, formerly Hemotech Sciences, Inc., and CIT entered into an
agreement on or about January 10, 1994, entitled Hemotech and CIT -
Amended and Restated Allosteric Modifiers of Hemoglobin Agreement
(hereinafter called the Agreement).
2. Allos and CIT wish to amend the Agreement as set forth in this
Amendment in order to (1) modify Paragraph 8, Operations to be in
Virginia, of the Agreement related to the location of Allos'
headquarters and (2) the intent to negotiate a lease for space in the
Virginia Biotechnology Park.
2.1. The first sentence in Paragraph 8.0 of the Agreement, which
reads "Hemotech shall locate its headquarters in Virginia," is
hereby deleted and amended.
2.2. Allos (Hemotech) agrees to immediately pursue discussions with
the intent to negotiate a lease for space in the Virginia
Biotechnology Research Park, subject to reasonable lease terms
(eg., per square foot cost, amount of space, term of lease)
and the occupancy of laboratory space by Xx. Xxxxxx Xxxxxxx'x
research group in the Biotechnology Park by December 31, 1996.
3. All terms in this Amendment shall be as defined in the Agreement.
4. The Agreement or this Amendment may be altered only in writing signed
by both parties.
ACCEPTED AND AGREED TO:
CENTER FOR INNOVATIVE TECHNOLOGY
By: /s/ XXXXXX X. XXXXXXX, XX. 3-12-96
------------------------------------- ------------------------------
Xxxxxx X. Xxxxxxx, Xx. Date
President
ALLOS THERAPEUTICS, INC.
By: /s/ XXXXXXX X. XXXXXXX 3/12/96
--------------------------------- ------------------------------
Xxxxxxx X. Xxxxxxx, Ph.D., M.D. Date
President
